When a foreign creditor's Russian asset recovery strategy in the pharmaceuticals sector intersects with OFAC sanctions, the operative question is not whether an OFAC licence removes all constraints, but which Russian-law procedural steps remain available within the compliance envelope established by US counsel.
The short answer is that Russian civil procedure, insolvency law, and interim relief mechanisms operate independently of OFAC's administrative framework. OFAC designations may block the transfer of funds or assets to or from a sanctioned party under US jurisdiction, but they do not suspend Russian court proceedings, eliminate a creditor's right to file a claim, or extinguish a pledge or security interest under Russian law. The two regimes run in parallel and must be managed in parallel.
In practice, the principal Russian-law procedural steps that remain available — and that foreign pharmaceutical creditors frequently overlook while awaiting OFAC licence determinations — are: first, preserving limitation periods by filing a claim in the relevant Russian arbitrazh court before the Russian statutory period expires, independent of OFAC status; second, registering any security interest or pledge with the relevant Russian registry to protect priority against competing creditors; third, applying for interim asset preservation measures (обеспечительные меры) from the arbitrazh court, which can freeze Russian-domiciled assets without requiring any transfer of value and therefore without triggering OFAC transfer prohibitions; and fourth, filing a creditor's claim in any insolvency proceeding the Russian counterparty may initiate, since failure to file within the statutory window permanently extinguishes priority. In pharmaceutical sector matters specifically, regulatory licences, product registration certificates, and intellectual property held by the Russian counterparty may constitute recoverable assets under Russian law that are not themselves directly within OFAC's scope.
The practical risk for foreign creditors is that OFAC licence processing timelines — which may extend well beyond 12 months for complex general licences — can cause Russian limitation periods to lapse if no protective steps are taken in Russian courts in the meantime.
For advice on coordinating OFAC compliance with a live Russian asset recovery strategy in the pharmaceuticals sector, see also OFAC Sanctions Intersection with Russian Asset Recovery Strategy — Practice Briefing and the Asset Tracing & Recovery practice page. For the Russian-law dimension of asset recovery more broadly, see What are the main procedural steps in Russian asset recovery?.
If your Russian pharmaceutical counterparty holds recoverable assets and OFAC compliance is complicating your recovery timeline — make an enquiry: info@vetrovpartners.com | WhatsApp/Telegram: +7 (983) 510-38-76
Vetrov & Partners is a Russian boutique law firm established in 2009, recognised by Pravo-300 for eight consecutive years. The firm's asset tracing and recovery practice advises foreign creditors — including those operating in regulated sectors — on Russian-law enforcement steps, interim relief, and creditor-side insolvency strategy. Direct partner involvement on every engagement.
Enquiries: info@vetrovpartners.com | WhatsApp / Telegram: +7 (983) 510-38-76 | t.me/vitvetcom
This publication is provided for informational purposes only and does not constitute legal advice under Russian or any other applicable law. The information herein should not be relied upon as a substitute for professional legal counsel tailored to your specific circumstances. Vetrov & Partners is a Russian-qualified law firm. For matters governed by foreign law or requiring local admission in another jurisdiction, we collaborate with trusted counsel in the relevant jurisdiction. For advice regarding your particular situation, please contact info@vetrovpartners.com.
-- Elizaveta Razina Senior Lawyer, Practice Lead -- IP Enforcement, Vetrov & Partners vetrovpartners.com/razina/
Elizaveta Razina leads the firm's intellectual property practice, representing foreign trademark owners in infringement proceedings before Russian state courts and the IP Court. She advises on asset protection strategy and has been with the firm since 2012.